Bone plates, screws and instruments

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Osteomed, Llc patent solves the following problem:

The present disclosure relates to bone plates, screws and other fasteners, and related instruments. included in the sample with a screw and washer systems with instruments, polyaxial screw and plate systems, bone clamp system with spacers, sleeves, and / or cages, multi-level bone clamp systems, minimally invasive bone clamp systems, motion preservation systems and instruments for handling plates, applying compression, and applying locking forces. More particularly, the present disclosure placed in the context of spinal surgery, such as spine fusion or motion preservation.

Our analysis of this patent is as follows:

Osteomed, Llc’s patent US 9456858 B2 deals with Bone plates, screws and instruments.
Systems for trauma and / or joint fusion implants and instruments included transarticular screw and intra-articular washer, polyaxial screw and plate, and multi-level polyaxial bone clamps, and minimally invasive adaptations.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Methods and compositions for the recombinant biosynthesis of n-alkanes

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Joule Unlimited Technologies, Inc. patent solves the following problem:

Many current photoautotrophic organisms (ie, plants, algae, and photosynthetic bacteria) are poorly suited for industrial bioprocessing and therefore not shown on commercial viability. These organisms often have slow doubling time (3-72 hrs) compared to industrialized heterotrophic organisms such as Escherichia coli (20 minutes), reflective of the lower total productivities. While a desire for orderly biosynthetic fuel production led to the development of photosynthesis microorganisms alkyl ester of fatty acids, a need still exists for methods of hydrocarbon, for example, alkanes, organisms use photosynthesis.

Our analysis of this patent is as follows:

Joule Unlimited Technologies, Inc.’s patent US 9458069 B2 deals with Methods and compositions for the recombinant biosynthesis of n-alkanes.
The present disclosure identifies methods and compositions for modification of photoautotrophic organisms as hosts, as the organism efficiently carbon dioxide and light to n-alkanes, and in particular the use of such organisms for commercial production of n-alkanes and related molecules.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Modified DNA-binding proteins and uses thereof

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Sangamo Biosciences, Inc. patent solves the following problem:

Transcription Activator Effector-like protein (story) is the protein encoded in the phytopathogenic bacteria of the genus Xanthomonas and Ralstonia influence gene expression in the host plant cells during bacterial infection. These proteins contain a DNA binding region and an A-terminal domain that appears to interact with bacteria in transport machinery to make proteins in plant cells. The C-terminal domain of the protein story seems to interact with the transcriptional machinery in the plant's army to induce expression of the gene set of plants useful to the invading bacteria. The DNA binding of the protein found in the middle section of the protein and made an array of repeated units, each approximately 33-35 amino acid long-on, which is shown to be responsible for association with the target DNA.

Our analysis of this patent is as follows:

Sangamo Biosciences, Inc.’s patent US 9458205 B2 deals with Modified DNA-binding proteins and uses thereof.
Expressed in enhanced polypeptides, polynucleotides encoding these polypeptides, cells and organisms that contain novel DNA-binding domain, including the story of DNA-binding domains. Also disclosed are methods of using these novel DNA-binding domains for modulation of gene expression and / or genomic editing of the endogenous cellular sequences.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Wearable heart rate monitor

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Fitbit, Inc. patent solves the following problem:

New consumer interest in personal health led to a kind of personal health monitoring devices offered on the market. Such devices, until recently, tended to be complicated to use and are usually designed for use in an activity, such as bicycle trip computer.

Our analysis of this patent is as follows:

Fitbit, Inc.’s patent US 9456787 B2 deals with Wearable heart rate monitor.
A biometric monitoring devices used to determine the heart rate of a user through the use of a heart rate waveform has a sensor and a motion detecting sensor. In some embodiments, the device collects simultaneously collecting data output from the sensor and output data heartbeat waveform there from motion detection sensor, can detect a periodic part of the data output from the motion detection sensor, and uses the periodic part of the data output from the motion detecting sensor to remove a corresponding each component of the data output from the heartbeat waveform there sensor. From these results, the device to determine and present the user's heart rate.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Soybean variety 01051789

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Monsanto Technology Llc patent solves the following problem:

The present invention relates generally to the field of soybean breeding. In particular, the invention relates to the novel soybean variety 01051789.

Our analysis of this patent is as follows:

Monsanto Technology Llc’s patent US 9456577 B1 deals with Soybean variety 01051789.
The invention relates to the soybean variety designated 01051789. If the invention are the seeds, plants and derivatives of the soybean variety 01051789. also given to create the tissue culture of soybean 01051789 and plants rescued it. Still further provided by the invention are methods for producing a soybean plant by crossing soybean variety 01051789 with itself or another soybean variety and plants produced by such methods.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Rear-mounted aerodynamic structures for cargo bodies

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Stemco Lp patent solves the following problem:

Trucking is the primary means of long-distance and short-haul transportation of goods and materials in the United States, and in many other countries. Trucks often include a motorized cab where the driver sits and working on cars. cab attached to a box-like cargo section. Smaller trucks often include an integrated cargo section sitting in a unified framework which extends from the front wheels to the rear wheel assembly. The larger trucks often includes a detachable cab unit, with many driven axles, and a special trailer with a long box-like cargo units served on two or more phrases assemblies wheels. These trucks assemblages commonly called semi-trailers or tractor trailers. Most modern trucks' cabs, especially for tractor trailers, fitted with aerodynamic fairings on the roof, side and front. These fairings to help direct air over the exposed surface of the box-like cargo body, generally gave higher (a few feet) than the average roof cab. The flat, projecting front face of a cargo body is a strong source of drag on the cab roof. The use of the front-mounted aerodynamic fairings in recent years have served to significantly lower drag and, therefore, raise fuel economy for trucks, especially those traveling at high speed in the open roads.

Our analysis of this patent is as follows:

Stemco Lp’s patent US 9457847 B2 deals with Rear-mounted aerodynamic structures for cargo bodies.
A rear-mounted aerodynamic framework for taking a cargo body includes a three or four-sided structure with a deployed position to help improve flight efficiency in cargo body. The cargo body may be the body of a trailer of a tractor-trailer vehicle or trailer towed behind a vehicle like a truck. It consists of a trailer body or other body cargo well-known in the art. A destroyer run guard mounted on a top surface of the rear cargo body, as additional aerodynamic structures or as a standalone destroyer for cargo bodies. The three or four-sided rear-mounted aerodynamic structure can contain any of a variety of illustrative embodiments shown and described herein.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Bis-acylated hydroxylamine derivatives

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Cardioxyl Pharmaceuticals, Inc., , The Johns Hopkins University patent solves the following problem:

Our analysis of this patent is as follows:

Cardioxyl Pharmaceuticals, Inc., , The Johns Hopkins University’s patent US 9458127 B2 deals with Bis-acylated hydroxylamine derivatives.
invention provides several bis-acylated hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the invention provides methods of using such compounds or medicine composition for treating, preventing, or delaying the onset and / or develop a disease or condition. In some embodiments, the disease or condition is selected from cardiovascular disease, ischemia, reperfusion injury, cancerous disease, pulmonary hypertension and the condition responsive to nitroxyl therapy.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Recombinant antibodies against H1N1 influenza

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Emory University, , The University Of Chicago patent solves the following problem:

The swine H1N1 influenza virus now causing a global pandemic associated with substantial morbidity and mortality1-5. This newly emergent strain is immunologically different from other influenza viruses including the new H1N1 strains6 thus leaving a large population of the world are very susceptible to infection of pandemic virus7. Although there are some B cell cross-reactivity with seasonal influenza virus protective epitopes swine H1N1 virus so that race.

Our analysis of this patent is as follows:

Emory University, , The University Of Chicago’s patent US 9458226 B2 deals with Recombinant antibodies against H1N1 influenza.
Antibodies that bind with high affinity to the swine H1N1 virus described. In vivo experiments showed that the antibody could completely protect the mice were challenged with a lethal dose of the swine H1N1 virus. antibody is able to cure mice in a therapeutic situation when treated as late as 60 hours (2.5 days) after the infection with swine H1N1 virus. Also described the artificial kind of antibody.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Golf aid including heads up display

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Nike, Inc. patent solves the following problem:

The game of golf is a popular sport at both amateur and professional levels. Both amateur and professional golfers spend large amounts of time to develop muscle memory and fine motor skills needed to improve their game. Golfers try to improve their game by analyzing launch and trajectory information while playing golf. Golf balls are sometimes difficult to see when flying in the air on a golf course. Therefore, it can be difficult to monitor the trajectory of a golf ball and find the golf balls after they landed. Therefore, it is useful to provide a system for tracking a golf ball.

Our analysis of this patent is as follows:

Nike, Inc.’s patent US 9457246 B2 deals with Golf aid including heads up display.
A golf aid includes a user tracking system configured to determine the location of a user on a golf course, a processor, and a display head. The heads of the display is configured to be worn on the user's head, and the display of an image in a field of view of the user. processor is in communication with the tracking system user and with the heads of the display, and configured to determine a distance between the location of the user and a thing, and give a indication of the determined distance to the user through the display head.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases

Use PowerPatent’s Online Patent Filing Service to get quick patent protection for your great idea.

The Raqualia Pharma Inc. patent solves the following problem:

Prostaglandin E2 (PGE2) is a potent modulator involved in the pathogenesis of a variety of diseases such as inflammation, pain, arthritis, and cancer. PGE2 binds to at least four subtypes of the PGE receptor, designated EP1, EP2, EP3, and EP4. Molecular Pharmacology study revealed that all subtypes of 7-transmembrane spanning cells that belong to the G-protein coupled receptor type. EP1 activation stimulates the release of intracellular calcium; EP2 and EP4 stimulation both activate the adenylate cyclase but differ in their responses to certain ligands; and EP3 stimulation inhibits adenylate cyclase by the inhibitory G-protein (NPL 1).

Our analysis of this patent is as follows:

Raqualia Pharma Inc.’s patent US 9457084 B2 deals with Use of EP4 receptor antagonists in the treatment of IL-23 mediated diseases.
This invention relates to a compound of EP4 antagonistic activity, or a pharmaceutically acceptable salt EP4 receptor antagonistic activity, which is useful in the treatment of immune disorders or allergies. This invention also relates to a compound of formula (I), (II), (III), (IV), (Va) or (VB), or a pharmaceutically acceptable salt thereof with the EP4 receptor antagonistic activity, which is useful in the treatment of immune disorders or allergies. This invention also relates to a pharmaceutical composition for the treatment of immune diseases or allergies comprising a therapeutically effective amount of a compound of formula (I), (II), (III), (IV), (Va) or (VB), or a pharmaceutically acceptable salt thereof. Furthermore this invention relates to a method for the treatment of immune disorders or allergies in an animal subject including a mammal subject, comprising administering to the subject an animal including a mammal subject a compound of formula (I), (II), (III), (IV), (Va) or (VB), or a pharmaceutically acceptable salt thereof.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.